166 related articles for article (PubMed ID: 12502361)
1. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP
J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361
[TBL] [Abstract][Full Text] [Related]
2. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and characterization of mouse CYP2d22.
Yu AM; Haining RL
Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
[TBL] [Abstract][Full Text] [Related]
4. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.
Smith G; Modi S; Pillai I; Lian LY; Sutcliffe MJ; Pritchard MP; Friedberg T; Roberts GC; Wolf CR
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):783-92. PubMed ID: 9560305
[TBL] [Abstract][Full Text] [Related]
5. Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding.
McLaughlin LA; Paine MJ; Kemp CA; Maréchal JD; Flanagan JU; Ward CJ; Sutcliffe MJ; Roberts GC; Wolf CR
J Biol Chem; 2005 Nov; 280(46):38617-24. PubMed ID: 16162505
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism.
Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
Xenobiotica; 1997 Apr; 27(4):319-39. PubMed ID: 9149373
[TBL] [Abstract][Full Text] [Related]
7. Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.
Lewis DF
Arch Biochem Biophys; 2003 Jan; 409(1):32-44. PubMed ID: 12464242
[TBL] [Abstract][Full Text] [Related]
8. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure.
Lewis DF
Xenobiotica; 2002 Apr; 32(4):305-23. PubMed ID: 12028664
[TBL] [Abstract][Full Text] [Related]
9. Regional and cellular distribution of CYP2D subfamily members in rat brain.
Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
[TBL] [Abstract][Full Text] [Related]
10. Progress in cytochrome P450 active site modeling.
Kemp CA; Maréchal JD; Sutcliffe MJ
Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
[TBL] [Abstract][Full Text] [Related]
11. The endogenous substrates of brain CYP2D.
Wang X; Li J; Dong G; Yue J
Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
13. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
Lewis DF
Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
[TBL] [Abstract][Full Text] [Related]
14. A molecular model of CYP2D6 constructed by homology with the CYP2C5 crystallographic template: investigation of enzyme-substrate interactions.
Lewis DF; Dickins M; Lake BG; Goldfarb PS
Drug Metabol Drug Interact; 2003; 19(3):189-210. PubMed ID: 14682610
[TBL] [Abstract][Full Text] [Related]
15. The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
Narimatsu S; Kiryu K; Yonemoto R; Yoshino M; Kobatake M; Kazamori D; Hagino S; Masuda K; Katsu T; Asanuma M; Kumamoto T; Ishikawa T; Funae Y; Yamano S; Hanioka N; Naito S
Chem Biol Interact; 2008 Mar; 172(1):11-21. PubMed ID: 18191824
[TBL] [Abstract][Full Text] [Related]
16. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of canine cytochrome P450 2D15.
Roussel F; Duignan DB; Lawton MP; Obach RS; Strick CA; Tweedie DJ
Arch Biochem Biophys; 1998 Sep; 357(1):27-36. PubMed ID: 9721180
[TBL] [Abstract][Full Text] [Related]
18. Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation.
Grobe N; Kutchan TM; Zenk MH
FEBS Lett; 2012 Jun; 586(13):1749-53. PubMed ID: 22641033
[TBL] [Abstract][Full Text] [Related]
19. Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamily.
Lewis DF; Ito Y; Goldfarb PS
Curr Drug Metab; 2006 Aug; 7(6):589-98. PubMed ID: 16918314
[TBL] [Abstract][Full Text] [Related]
20. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
